Akt1/protein kinase Bα is involved in gastric cancer progression and cell proliferation

被引:74
作者
Han, Zheyi [1 ]
Wu, Kaichun [1 ]
Shen, Huiqin [1 ]
Li, Chunying [2 ]
Han, Shuang [1 ]
Hong, Liu [1 ]
Shi, Yongquan [1 ]
Liu, Na [1 ]
Guo, Changcun [1 ]
Xue, Yan [1 ]
Qiao, Taidong [1 ]
Fan, Daiming [1 ]
机构
[1] Fourth Mil Med Univ, Xijing Hosp, Inst Digest Dis, State Key Lab Canc Bio, Xian 710032, Peoples R China
[2] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Peoples R China
基金
中国国家自然科学基金;
关键词
Akt1; protein kinase B alpha; gastric cancer; proliferation; cell cycle;
D O I
10.1007/s10620-007-9824-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Akt (also known as protein kinase B, PKB) is involved in a variety of biological processes, for example cell development, proliferation, and angiogenesis. Clinical studies in support of the idea that increased activity of Akt could contribute directly to gastric carcinogenesis are rare, however. In this study we discovered that phospho-Akt1 was overexpressed in human gastric cancers and its levels correlated with tumor differentiation and pTNM. Akt1 activation promoted cell survival, because the phosphatidylinositol 3-kinase(PI3K) inhibitor LY294002 inhibited Akt1 phosphorylation and inhibited cell growth, especially in cells with active Akt1. Dominant negative Akt inhibited proliferation of gastric cancer cells and induced G1 cell-cycle arrest whereas constitutively active Akt increased cell proliferation. We have therefore identified Akt1 as an active kinase that contributes to gastric cancer progression and promotes proliferation of gastric cancer cells.
引用
收藏
页码:1801 / 1810
页数:10
相关论文
共 31 条
[1]
Gastric cancer: epidemiology, pathology and treatment [J].
Alberts, SR ;
Cervantes, A ;
van de Velde, CJH .
ANNALS OF ONCOLOGY, 2003, 14 :31-36
[2]
Role of translocation in the activation and function of protein kinase B [J].
Andjelkovic, M ;
Alessi, DR ;
Meier, R ;
Fernandez, A ;
Lamb, NJC ;
Frech, M ;
Cron, P ;
Cohen, P ;
Lucocq, JM ;
Hemmings, BA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (50) :31515-31524
[3]
MOLECULAR ALTERATIONS OF THE AKT2 ONCOGENE IN OVARIAN AND BREAST CARCINOMAS [J].
BELLACOSA, A ;
DEFEO, D ;
GODWIN, AK ;
BELL, DW ;
CHENG, JQ ;
ALTOMARE, DA ;
WAN, MH ;
DUBEAU, L ;
SCAMBIA, G ;
MASCIULLO, V ;
FERRANDINA, G ;
PANICI, PB ;
MANCUSO, S ;
NERI, G ;
TESTA, JR .
INTERNATIONAL JOURNAL OF CANCER, 1995, 64 (04) :280-285
[4]
Reversion of the malignant phenotype of gastric cancer cell SGC7901 by c-erbB-2-specific hammerhead ribozyme [J].
Bi, F ;
Fan, DM ;
Hui, HX ;
Wang, CJ ;
Zhang, XY .
CANCER GENE THERAPY, 2001, 8 (11) :835-842
[5]
Translocation of Akt/PKB to the nucleus of osteoblast-like MC3T3-E1 cells exposed to proliferative growth factors [J].
Borgatti, P ;
Martelli, AM ;
Bellacosa, A ;
Casto, R ;
Massari, L ;
Capitani, S ;
Neri, LM .
FEBS LETTERS, 2000, 477 (1-2) :27-32
[6]
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]
Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma [J].
Chariyalertsak, S ;
Sirikulchayanonta, V ;
Mayer, D ;
Kopp-Schneider, A ;
Fürstenberger, G ;
Marks, F ;
Müller-Decker, K .
GUT, 2001, 48 (01) :80-86
[8]
Amplification of AKT2 in human pancreatic cancer cells and inhibition of ATK2 expression and tumorigenicity by antisense RNA [J].
Cheng, JQ ;
Ruggeri, B ;
Klein, WM ;
Sonoda, G ;
Altomare, DA ;
Watson, DK ;
Testa, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (08) :3636-3641
[9]
The Akt/PKB pathway: molecular target for cancer drug discovery [J].
Cheng, JQ ;
Lindsley, CW ;
Cheng, GZ ;
Yang, H ;
Nicosia, SV .
ONCOGENE, 2005, 24 (50) :7482-7492
[10]
CORREA P, 1988, CANCER RES, V48, P3554